SOCIETAL CDMO INC (SCTL) Fundamental Analysis & Valuation

NASDAQ:SCTL • US75629F1093

Current stock price

1.1 USD
+0.01 (+0.92%)
At close:
1.09 USD
-0.01 (-0.91%)
After Hours:

This SCTL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. SCTL Profitability Analysis

1.1 Basic Checks

  • SCTL had negative earnings in the past year.
  • In the past year SCTL has reported a negative cash flow from operations.
  • SCTL had negative earnings in each of the past 5 years.
  • In multiple years SCTL reported negative operating cash flow during the last 5 years.
SCTL Yearly Net Income VS EBIT VS OCF VS FCFSCTL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

  • SCTL has a Return On Assets of -8.64%. This is in the better half of the industry: SCTL outperforms 74.37% of its industry peers.
  • SCTL has a Return On Equity of -22.61%. This is in the better half of the industry: SCTL outperforms 72.86% of its industry peers.
Industry RankSector Rank
ROA -8.64%
ROE -22.61%
ROIC N/A
ROA(3y)-9.46%
ROA(5y)-14.37%
ROE(3y)-27.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SCTL Yearly ROA, ROE, ROICSCTL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 300 400

1.3 Margins

  • SCTL's Gross Margin of 19.17% is in line compared to the rest of the industry. SCTL outperforms 49.75% of its industry peers.
  • SCTL's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SCTL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y-15.39%
SCTL Yearly Profit, Operating, Gross MarginsSCTL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. SCTL Health Analysis

2.1 Basic Checks

  • SCTL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SCTL has more shares outstanding
  • SCTL has a better debt/assets ratio than last year.
SCTL Yearly Shares OutstandingSCTL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
SCTL Yearly Total Debt VS Total AssetsSCTL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -1.24, we must say that SCTL is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.24, SCTL is in line with its industry, outperforming 48.74% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that SCTL is not too dependend on debt financing.
  • The Debt to Equity ratio of SCTL (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -1.24
ROIC/WACCN/A
WACC11.28%
SCTL Yearly LT Debt VS Equity VS FCFSCTL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

2.3 Liquidity

  • SCTL has a Current Ratio of 1.07. This is a normal value and indicates that SCTL is financially healthy and should not expect problems in meeting its short term obligations.
  • SCTL has a worse Current ratio (1.07) than 85.93% of its industry peers.
  • A Quick Ratio of 0.86 indicates that SCTL may have some problems paying its short term obligations.
  • SCTL has a worse Quick ratio (0.86) than 83.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.86
SCTL Yearly Current Assets VS Current LiabilitesSCTL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. SCTL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 40.74% over the past year.
  • The Revenue has been growing slightly by 4.91% in the past year.
  • The Revenue has been growing slightly by 4.12% on average over the past years.
EPS 1Y (TTM)40.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
Revenue 1Y (TTM)4.91%
Revenue growth 3Y12.48%
Revenue growth 5Y4.12%
Sales Q2Q%14.16%

3.2 Future

  • The Earnings Per Share is expected to grow by 31.13% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 9.11% on average over the next years. This is quite good.
EPS Next Y45.81%
EPS Next 2Y27.18%
EPS Next 3Y31.13%
EPS Next 5YN/A
Revenue Next Year2.59%
Revenue Next 2Y4.69%
Revenue Next 3Y6.13%
Revenue Next 5Y9.11%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SCTL Yearly Revenue VS EstimatesSCTL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
SCTL Yearly EPS VS EstimatesSCTL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. SCTL Valuation Analysis

4.1 Price/Earnings Ratio

  • SCTL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SCTL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SCTL Price Earnings VS Forward Price EarningsSCTL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SCTL is valued a bit cheaper than the industry average as 78.89% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.26
SCTL Per share dataSCTL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • SCTL's earnings are expected to grow with 31.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.18%
EPS Next 3Y31.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SCTL Dividend Analysis

5.1 Amount

  • No dividends for SCTL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SCTL Fundamentals: All Metrics, Ratios and Statistics

SOCIETAL CDMO INC

NASDAQ:SCTL (4/5/2024, 8:19:35 PM)

After market: 1.09 -0.01 (-0.91%)

1.1

+0.01 (+0.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-22
Earnings (Next)05-08
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner Change0%
Market Cap116.26M
Revenue(TTM)94.64M
Net Income(TTM)-13.27M
Analysts78
Price Target1.12 (1.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-71.57%
Min EPS beat(2)-145.1%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-44.61%
Min EPS beat(4)-145.1%
Max EPS beat(4)1.96%
EPS beat(8)5
Avg EPS beat(8)-15.62%
EPS beat(12)9
Avg EPS beat(12)5.08%
EPS beat(16)10
Avg EPS beat(16)-57.49%
Revenue beat(2)1
Avg Revenue beat(2)0.76%
Min Revenue beat(2)-4.6%
Max Revenue beat(2)6.12%
Revenue beat(4)2
Avg Revenue beat(4)1.07%
Min Revenue beat(4)-4.6%
Max Revenue beat(4)6.12%
Revenue beat(8)4
Avg Revenue beat(8)2%
Revenue beat(12)7
Avg Revenue beat(12)1.72%
Revenue beat(16)9
Avg Revenue beat(16)-0.52%
PT rev (1m)-47.2%
PT rev (3m)-47.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.23
P/FCF N/A
P/OCF N/A
P/B 1.98
P/tB 7.58
EV/EBITDA 27.26
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.9
BVpS0.56
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.64%
ROE -22.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.17%
FCFM N/A
ROA(3y)-9.46%
ROA(5y)-14.37%
ROE(3y)-27.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y-15.39%
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.06
Cap/Depr 92.47%
Cap/Sales 8.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 0.86
Altman-Z -1.24
F-Score4
WACC11.28%
ROIC/WACCN/A
Cap/Depr(3y)87.57%
Cap/Depr(5y)90.2%
Cap/Sales(3y)8.33%
Cap/Sales(5y)8.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
EPS Next Y45.81%
EPS Next 2Y27.18%
EPS Next 3Y31.13%
EPS Next 5YN/A
Revenue 1Y (TTM)4.91%
Revenue growth 3Y12.48%
Revenue growth 5Y4.12%
Sales Q2Q%14.16%
Revenue Next Year2.59%
Revenue Next 2Y4.69%
Revenue Next 3Y6.13%
Revenue Next 5Y9.11%
EBIT growth 1Y-1334.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year472.86%
EBIT Next 3Y112.66%
EBIT Next 5YN/A
FCF growth 1Y22.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y72.39%
OCF growth 3YN/A
OCF growth 5YN/A

SOCIETAL CDMO INC / SCTL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SOCIETAL CDMO INC?

ChartMill assigns a fundamental rating of 2 / 10 to SCTL.


What is the valuation status of SOCIETAL CDMO INC (SCTL) stock?

ChartMill assigns a valuation rating of 1 / 10 to SOCIETAL CDMO INC (SCTL). This can be considered as Overvalued.


Can you provide the profitability details for SOCIETAL CDMO INC?

SOCIETAL CDMO INC (SCTL) has a profitability rating of 2 / 10.


What is the financial health of SOCIETAL CDMO INC (SCTL) stock?

The financial health rating of SOCIETAL CDMO INC (SCTL) is 2 / 10.


Can you provide the expected EPS growth for SCTL stock?

The Earnings per Share (EPS) of SOCIETAL CDMO INC (SCTL) is expected to grow by 45.81% in the next year.